IP Library Granted Patent US 12,263,115
Granted Patent B2
US 12,263,115 · App. 16/127,870 · Granted Apr 1, 2025

Forceps treatment systems

Inventors: Paul Badawi (Menlo Park, CA); David Badawi (Glenview, IL)
Assignee: Sight Sciences, Inc.
A61F7/007A61F7/02A61F2007/0004A61F2007/0075A61F2007/0093A61F2007/0094
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,263,115
App. No.
16/127,870
Granted
Apr 1, 2025
Kind
B2
Abstract

Forceps treatment systems are described in which a forceps apparatus may generally comprise a first handle and a second handle coupled to one another near or at respective proximal ends. A first paddle may be coupled to the first handle and define a first inner surface, a second paddle may be coupled to the second handle and define a second inner surface which is positioned in apposition to the first inner surface. Furthermore, a debriding member may extend proximally from the first and second handles and reduce and curve gently to define a debriding edge for debriding tissue in proximity to one or more meibomian glands. The forceps apparatus may be used in combination with a heat treatment for treating one or more meibomian glands in a subject.

Claims (24)

1. A forceps apparatus, comprising:

a first handle and a second handle coupled to one another near or at respective proximal ends via a common pivoting connection such that in a first unbiased configuration the first and second handle are spaced apart and in a second biased configuration the first and second handle are urged towards one another about the pivoting connection when squeezed together, wherein the first and second handles each have a thickness which reduces proximally of the pivoting connection;

a first paddle coupled to the first handle and defining a first inner surface;

a second paddle coupled to the second handle and defining a second inner surface which is positioned in apposition to the first inner surface, wherein the first and second paddles define a plane when compressed against one another; and

a planar debriding member extending proximally from the first and second handles and having a planar thickness which reduces and curves gently to define a debriding edge around a periphery of the planar thickness and having a radius such that the debriding edge is sufficiently configured to scrape tissue along a margin of an eyelid in proximity to one or more meibomian glands,

wherein the debriding member defines a debriding plane which is coplanar or parallel with the plane defined by the first and second paddles when compressed, and

wherein the planar thickness is relatively thinner from the first and second handles for debriding the margin and the planar thickness is also relatively thinner than the pivoting connection.

2. The apparatus of claim 1 wherein the debriding member has a length between 10.00 mm to 11.00 mm.

3. The apparatus of claim 1 wherein the debriding member has a width between 8.00 mm to 9.00 mm.

4. The apparatus of claim 1 wherein the debriding member has a thickness of between 0.40 mm to 0.55 mm.

5. The apparatus of claim 1 wherein the debriding member reduces and curves gently into an elliptical shape.

6. The apparatus of claim 1 wherein the first and second paddles are separated by a resting open gap when uncompressed against one another.

7. The apparatus of claim 1 wherein the periphery of the planar thickness presents a smooth transition to the pivoting connection.

8. The apparatus of claim 1 wherein a length of the first and second paddles defines an angle of 35° relative to a longitudinal axis of the forceps.

9. The apparatus of claim 1 further comprising one or more strips configured to adhere to an underlying region of skin in proximity to one or both eyes of a subject such that the one or more strips allow for the subject to blink naturally with minimal, or no restriction from the one or more strips.

10. The apparatus of claim 9 wherein the one or more strips are configured to emit thermal energy to the underlying region of skin, and wherein the one or more strips are shaped to follow a location of one or more meibomian glands contained within the underlying region of skin.

11. The apparatus of claim 9 further comprising a controller in communication with the one or more strips, wherein the controller is programmable to monitor and induce a temperature in the one or more strips to provide a therapy.

12. A forceps apparatus, comprising:

a first handle and a second handle coupled to one another near or at respective proximal ends via a common pivoting connection, wherein the first and second handles each have a thickness which reduces proximally of the pivoting connection;

a first paddle coupled to the first handle and defining a first inner surface;

a second paddle coupled to the second handle and defining a second inner surface which is positioned in apposition to the first inner surface, wherein the first and second paddles define a plane when compressed against one another; and

a member extending proximally from the first and second handles and having a planar thickness which reduces and curves gently to present an atraumatic proximal edge around a periphery of the planar thickness and having a flattened thickness which is also relatively thinner than the pivoting connection,

wherein the member is coplanar or parallel with the plane defined by the first and second paddles when compressed and further defines a notch having a recessed, atraumatic debriding edge along a curved edge of the flattened thickness in proximity to the proximal edge and sized for receiving and maintaining a lid margin within the notch.

13. The apparatus of claim 12 wherein the notch further defines atraumatic side edges on either side of the recessed debriding edge.

Assignments (8)
SECURITY INTEREST Recorded Jan 23, 2024
From: SIGHT SCIENCES, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 066364/0162 →
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: MIDCAP FUNDING IV TRUST
To: SIGHT SCIENCES, INC.
Reel/Frame 064354/0155 →
REAFFIRMED AND AMENDED SECURITY INTEREST (TERM) Recorded Nov 25, 2020
From: SIGHT SCIENCES, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 054524/0020 →
REAFFIRMED AND AMENDED SECURITY INTEREST (REVOLVING) Recorded Nov 25, 2020
From: SIGHT SCIENCES, INC.
To: MIDCAP FUNDING IV TRUST, AS AGENT
Reel/Frame 054524/0008 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2019
From: BADAWI, DAVID; BADAWI, PAUL
To: SIGHT SCIENCES, INC.
Reel/Frame 048323/0307 →
SECURITY AGREEMENT (REVOLVING LOAN) Recorded Jan 28, 2019
From: SIGHT SCIENCES, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 049670/0542 →
SECURITY AGREEMENT (TERM LOAN) Recorded Jan 28, 2019
From: SIGHT SCIENCES, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 048149/0209 →
SECURITY AGREEMENT (REVOLVING LOAN) Recorded Jan 28, 2019
From: SIGHT SCIENCES, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 048149/0230 →
Continuity (1)
Related Publication 20200078211A1 · Mar 12, 2020
References Cited (203)
US 2001862A · Carter · 1935 [cited by applicant]
US 2108934A · Albright · 1938 [cited by applicant]
US 2635175A · Hodge · 1953 [cited by applicant]
US 3075527A · Bechtold · 1963 [cited by applicant]
US 3173419A · Dublier et al. · 1965 [cited by applicant]
US 3589369A · Alksnis · 1971 [cited by applicant]
US 4096864A · Kletschka et al. · 1978 [cited by applicant]
US 4261364A · Haddad et al. · 1981 [cited by applicant]
US 4325254A · Svacina et al. · 1982 [cited by applicant]
US 4867146A · Krupnick et al. · 1989 [cited by applicant]
US 4930317A · Klein · 1990 [cited by applicant]
US 4962761A · Golden · 1990 [cited by applicant]
US 5097829A · Quisenberry · 1992 [cited by applicant]
US 5164987A · Raven · 1992 [cited by applicant]
US 5169384A · Bosniak et al. · 1992 [cited by applicant]
US 5643336A · Lopez-Claros · 1997 [cited by applicant]
US 5860985A · Anschutz · 1999 [cited by examiner]
US 6066164A · Macher et al. · 2000 [cited by applicant]
US 6074414A · Haas et al. · 2000 [cited by applicant]
US 6155995A · Lin · 2000 [cited by applicant]
US 6193741B1 · Heavenridge et al. · 2001 [cited by applicant]
US D441081S · Mueller · 2001 [cited by applicant]
US 6238427B1 · Matta · 2001 [cited by applicant]
US 6409746B1 · Igaki et al. · 2002 [cited by applicant]
US 6416534B1 · Montagnino et al. · 2002 [cited by applicant]
US 6511446B1 · Wu · 2003 [cited by applicant]
US 6860880B2 · Treat et al. · 2005 [cited by applicant]
US 6908195B2 · Fuller, Jr. · 2005 [cited by applicant]
US D507054S · Mueller et al. · 2005 [cited by applicant]
US D507055S · Mueller et al. · 2005 [cited by applicant]
US D507350S · Mueller et al. · 2005 [cited by applicant]
US D507651S · Mueller et al. · 2005 [cited by applicant]
US 6923988B2 · Patel et al. · 2005 [cited by applicant]
US D511573S · Mueller et al. · 2005 [cited by applicant]
US D513323S · Mueller et al. · 2005 [cited by applicant]
US 7069084B2 · Yee · 2006 [cited by applicant]
US 7108694B2 · Miura et al. · 2006 [cited by applicant]
US 7211070B2 · Soroudi · 2007 [cited by applicant]
US 7229468B2 · Wong, Jr. et al. · 2007 [cited by applicant]
US D613408S · Gausmann et al. · 2010 [cited by applicant]
US D614303S · Gausmann et al. · 2010 [cited by applicant]
US D614774S · Gausmann et al. · 2010 [cited by applicant]
US D617443S · Grenon et al. · 2010 [cited by applicant]
US 7758190B2 · Korb et al. · 2010 [cited by applicant]
US 7833205B2 · Grenon et al. · 2010 [cited by applicant]
US D638128S · Prokop et al. · 2011 [cited by applicant]
US 7976573B2 · Korb et al. · 2011 [cited by applicant]
US 7981095B2 · Grenon et al. · 2011 [cited by applicant]
US 7981145B2 · Korb et al. · 2011 [cited by applicant]
US 7981146B2 · Korb et al. · 2011 [cited by applicant]
US 7981147B2 · Korb et al. · 2011 [cited by applicant]
US 7988294B2 · Korb et al. · 2011 [cited by applicant]
US 8007524B2 · Korb et al. · 2011 [cited by applicant]
US 8025689B2 · Korb et al. · 2011 [cited by applicant]
US 8506539B2 · Guillon et al. · 2013 [cited by applicant]
US 8535363B1 · Lewis · 2013 [cited by applicant]
US 8685073B2 · Korb et al. · 2014 [cited by applicant]
US 8950405B2 · Grenon et al. · 2015 [cited by applicant]
US 8960204B2 · Samain et al. · 2015 [cited by applicant]
US 9510972B2 · Badawi · 2016 [cited by applicant]
US 9642743B2 · Badawi · 2017 [cited by applicant]
US 9724230B2 · Badawi · 2017 [cited by applicant]
US 9844459B2 · Badawi · 2017 [cited by applicant]
US 10052226B2 · Badawi et al. · 2018 [cited by applicant]
US 10772758B2 · Badawi · 2020 [cited by applicant]
US 10925765B2 · Badawi · 2021 [cited by applicant]
US 10973680B2 · Badawi et al. · 2021 [cited by applicant]
US 11285040B2 · Badawi et al. · 2022 [cited by applicant]
US 20020117495A1 · Kochman et al. · 2002 [cited by applicant]
US 20020180929A1 · Tseng et al. · 2002 [cited by applicant]
US 20030167556A1 · Kelley · 2003 [cited by applicant]
US 20030236487A1 · Knowlton · 2003 [cited by applicant]
US 20040044384A1 · Leeber et al. · 2004 [cited by applicant]
US 20040116990A1 · Agarwal et al. · 2004 [cited by applicant]
US 20040237969A1 · Fuller · 2004 [cited by applicant]
US 20050119629A1 · Soroudi · 2005 [cited by applicant]
US 20050159775A1 · Reynolds · 2005 [cited by applicant]
US 20050187502A1 · Krempel et al. · 2005 [cited by applicant]
US 20060018953A1 · Guillon et al. · 2006 [cited by applicant]
US 20060069420A1 · Rademacher et al. · 2006 [cited by applicant]
US 20060154642A1 · Scannell · 2006 [cited by applicant]
US 20060200052A1 · Lin · 2006 [cited by applicant]
US 20060219701A1 · Kil · 2006 [cited by applicant]
US 20060235497A1 · Zanotti · 2006 [cited by applicant]
US 20070016255A1 · Korb et al. · 2007 [cited by applicant]
US 20070060988A1 · Grenon et al. · 2007 [cited by applicant]
US 20080039749A1 · Kopanic et al. · 2008 [cited by applicant]
US 20080039769A1 · Peyman · 2008 [cited by applicant]
US 20080081999A1 · Gravely et al. · 2008 [cited by applicant]
US 20080109053A1 · Grenon et al. · 2008 [cited by applicant]
US 20080114421A1 · Korb et al. · 2008 [cited by applicant]
US 20080114423A1 · Grenon et al. · 2008 [cited by applicant]
US 20080114424A1 · Grenon et al. · 2008 [cited by applicant]
US 20080132978A1 · Korb et al. · 2008 [cited by applicant]
US 20080132987A1 · Westlund et al. · 2008 [cited by applicant]
US 20080269850A1 · Dodo · 2008 [cited by applicant]
US 20090020521A1 · Blaszczykiewicz et al. · 2009 [cited by applicant]
US 20090048590A1 · Conrad et al. · 2009 [cited by applicant]
US 20090137533A1 · Adkins, Jr. · 2009 [cited by applicant]
US 20090149925A1 · MacDonald et al. · 2009 [cited by applicant]
US 20090199571A1 · Creech et al. · 2009 [cited by applicant]
US 20090312823A1 · Patience et al. · 2009 [cited by applicant]
US 20100010598A1 · Igaki et al. · 2010 [cited by applicant]
US 20100114086A1 · Deem et al. · 2010 [cited by applicant]
US 20100172567A1 · Prokoski · 2010 [cited by applicant]
US 20100174501A1 · Myadam · 2010 [cited by applicant]
US 20100198282A1 · Rogers · 2010 [cited by applicant]
US 20100217360A1 · Henriksson et al. · 2010 [cited by applicant]
US 20100267751A1 · Beals et al. · 2010 [cited by applicant]
US 20100286654A1 · Dos Santos et al. · 2010 [cited by applicant]
US 20110046581A1 · Linder · 2011 [cited by applicant]
US 20110081333A1 · Shantha et al. · 2011 [cited by applicant]
US 20110198282A1 · Chu et al. · 2011 [cited by applicant]
US 20110275410A1 · Caffey et al. · 2011 [cited by applicant]
US 20120062840A1 · Ballou et al. · 2012 [cited by applicant]
US 20120191164A1 · Gander et al. · 2012 [cited by applicant]
US 20120213840A1 · Lim · 2012 [cited by applicant]
US 20120222192A1 · Carey et al. · 2012 [cited by applicant]
US 20130046367A1 · Chen · 2013 [cited by applicant]
US 20130083184A1 · Yogesan et al. · 2013 [cited by applicant]
US 20130172790A1 · Badawi · 2013 [cited by applicant]
US 20130172829A1 · Badawi · 2013 [cited by applicant]
US 20130281893A1 · Yang · 2013 [cited by applicant]
US 20130288196A1 · Gordon · 2013 [cited by examiner]
US 20140052198A1 · Mohn et al. · 2014 [cited by applicant]
US 20140276248A1 · Hall et al. · 2014 [cited by applicant]
US 20140303694A1 · Timme et al. · 2014 [cited by applicant]
US 20140316314A1 · Schubert · 2014 [cited by applicant]
US 20140330129A1 · Grenon et al. · 2014 [cited by applicant]
US 20150024339A1 · Calderon · 2015 [cited by examiner]
US 20150025545A1 · Grenon et al. · 2015 [cited by applicant]
US 20150216725A1 · Korb · 2015 [cited by examiner]
US 20160045755A1 · Chun et al. · 2016 [cited by applicant]
US 20160100977A1 · Lee et al. · 2016 [cited by applicant]
US 20160106576A1 · Badawi et al. · 2016 [cited by applicant]
US 20160106775A1 · Alster et al. · 2016 [cited by applicant]
US 20160317379A1 · Mosaddegh · 2016 [cited by applicant]
US 20170014300A1 · Dippo et al. · 2017 [cited by applicant]
US 20170079834A1 · Badawi · 2017 [cited by applicant]
US 20170079840A1 · Badawi · 2017 [cited by applicant]
US 20170087009A1 · Badawi · 2017 [cited by examiner]
US 20170165106A1 · Badawi · 2017 [cited by applicant]
US 20170188805A1 · Pradeep · 2017 [cited by applicant]
US 20170273823A1 · Novkov · 2017 [cited by examiner]
US 20170304110A1 · Badawi · 2017 [cited by applicant]
US 20180071140A1 · Sheydin · 2018 [cited by applicant]
US 20180200494A1 · Gatrall · 2018 [cited by examiner]
US 20180344512A1 · Badawi · 2018 [cited by applicant]
US 20190274873A1 · Schoeggler · 2019 [cited by applicant]
US 20200078032A1 · Nanda · 2020 [cited by examiner]
US 20200188169A1 · McMahon · 2020 [cited by examiner]
US 20210022914A1 · Badawi et al. · 2021 [cited by applicant]
US 20210052216A1 · Badawi · 2021 [cited by applicant]
US 20210169682A1 · Alvarez et al. · 2021 [cited by applicant]
US 20210177647A1 · Badawi · 2021 [cited by applicant]
US 20210177648A1 · Badawi et al. · 2021 [cited by applicant]
US 20220168136A1 · Badawi et al. · 2022 [cited by applicant]
CN 202313590 · 2012 [cited by applicant]
CN 103417306 · 2013 [cited by applicant]
CN 203493672 · 2014 [cited by applicant]
CN 203564408 · 2014 [cited by applicant]
CN 205234758 · 2016 [cited by applicant]
CN 205568977 · 2016 [cited by applicant]
DE 29920352 · 2000 [cited by applicant]
JP 1995185017 · 1995 [cited by applicant]
JP 3071816 · 2000 [cited by applicant]
JP 2003093431 · 2003 [cited by applicant]
JP 2007520A · 2007 [cited by applicant]
JP 2007185017 · 2007 [cited by applicant]
JP 2007229175A · 2007 [cited by applicant]
JP 2010504769 · 2010 [cited by applicant]
JP 2010515481 · 2010 [cited by applicant]
JP 2011188958 · 2011 [cited by applicant]
JP 3170844 · 2011 [cited by applicant]
JP 2015503417 · 2015 [cited by applicant]
JP 2015527122 · 2015 [cited by applicant]
JP 2020199386 · 2020 [cited by applicant]
KR 200301311 · 2003 [cited by applicant]
KR 20100002818 · 2010 [cited by applicant]
WO WO1994011739 · 1994 [cited by applicant]
WO WO1999020213 · 1999 [cited by applicant]
WO WO2000069506 · 2000 [cited by applicant]
WO WO2002067688 · 2002 [cited by applicant]
WO WO2004006801 · 2004 [cited by applicant]
WO WO2006099413 · 2006 [cited by applicant]
WO WO2007102362 · 2007 [cited by applicant]
WO WO2008085162 · 2008 [cited by applicant]
WO WO2008100647 · 2008 [cited by applicant]
WO WO2013103413 · 2013 [cited by applicant]
WO WO2016070134 · 2016 [cited by applicant]
WO WO2017100608 · 2017 [cited by applicant]
WO WO2020055634 · 2019 [cited by applicant]
WO WO2021026154 · 2021 [cited by applicant]
Blackie, Caroline A. et al., “Inner Eyelid Surface Temperature as a Function of Warm Compress Methodology,” [cited by applicant]
Bron, A.J. et al., “Functional Aspects of the Tear Film Lipid Layer,” [cited by applicant]
Driver, Paul J. et al., “Meibomian Gland Dysfunction,” Survey of Ophthalmology, vol. 40, No. 5, pp. 343-367, Mar.-Apr. 1996. [cited by applicant]
Gifford, Sanford R., “Meibomian Glands in Chronic Blepharo-Conjunctivitis,” [cited by applicant]
Goto, E. et al., “Treatment of Non-Inflamed Obstructive Meibomian Gland Dysfunction by an Infrared Warm Compression Device,” [cited by applicant]
Olson, Mary Catherine et al., “Increase in Tear Film Lipid Layer Thickness Following Treatment with Warm Compresses in Patients with Meibomian Gland Dysfunction,” [cited by applicant]
Ong, Bee-Leng, “Clinical Diagnosis and Management of Meibomian Gland Dysfunction,” [cited by applicant]
Leahy-Smith America Invents Act, H.R.1249, 112th Cong. (2011), https://www.congress.gov/bill/112th-congress/house-bill/1249 H.R.1249—112th Congress (2011-2012). [cited by applicant]
U.S. Appl. No. 15/374,426, filed Dec. 6, 2016 in the name of Badawi et al., Non-Final Office Action mailed Sep. 1, 2020. [cited by applicant]
Lee, Jeanette, OD shares drug-free approach to treating meibomian gland dysfunction, https://www.healio.com/news/optometry/20120225/od-shares-drug-free-approach-to-treating-meibomian-gland-dysfunction, published: Nov. 1… [cited by applicant]